Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Jazz Pharmaceuticals plc shares valued at $185,145 were sold by COZADD BRUCE C on Jan 02 ’25. At $123.43 per share, COZADD BRUCE C sold 1,500 shares. The insider’s holdings dropped to 425,525 shares worth approximately $52.88 million following the completion of this transaction.
Also, COZADD BRUCE C purchased 1,500 shares, netting a total of over 185,145 in proceeds.
Before that, COZADD BRUCE C had sold 2,000 shares from its account. In a trade valued at $242,340, the Chairman & CEO traded Jazz Pharmaceuticals plc shares for $121.17 each. Upon closing the transaction, the insider’s holdings decreased to 2,000 shares, worth approximately $53.07 million.
As published in a research note from Morgan Stanley on December 12, 2024, Jazz Pharmaceuticals plc [JAZZ] has been rated up from an Equal-weight to an Overweight and the price target has been revised to $175 from $140. Analysts at Goldman started covering the stock with ‘”a Buy”‘ outlook in a report released in early June. As of January 03, 2024, Robert W. Baird has initiated its “an Outperform” rating for JAZZ. Earlier on November 27, 2023, UBS downgraded its rating. Their new recommendation was “a Neutral” for JAZZ stock which previously was a “a Buy”.
Analyzing JAZZ Stock Performance
During the last five days, there has been a surge of approximately 2.84%. Over the course of the year, Jazz Pharmaceuticals plc shares have jumped approximately 0.91%. Shares of the company reached a 52-week high of $126.12 on 01/28/25 and a 52-week low of $118.72 on 01/10/25. A 50-day SMA is recorded $122.51, while a 200-day SMA reached $113.22. Nevertheless, trading volume fell to 0.52 million shares from 0.49 million shares the previous day.
Support And Resistance Levels for Jazz Pharmaceuticals plc (JAZZ)
According to the 24-hour chart, there is a support level at 122.91, which, if violated, would cause prices to drop to 121.54. In the upper region, resistance lies at 125.74. The next price resistance is at 127.21. RSI (Relative Strength Index) is 55.95 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.65, which suggests the price will increase in the coming days. Percent R is at 25.00%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
